SCHEMBL6646406

SCHEMBL6646406

CCc1ccncc1-c1nc(-c2ccc(Cl)cc2)cs1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.61
RAB9A P51151 4/20 0.61
LMNA P02545 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
CYP19A1 P11511 6/20 0.58
SREBF2 Q12772 1/20 0.51
MAPT P10636 3/20 0.50
ATM Q13315 1/20 0.50
NPC1 O15118 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 3/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GPR55 Q9Y2T6 1/20 0.46
IDH1 O75874 1/20 0.46
PLAU P00749 2/20 0.45
MAPK1 P28482 1/20 0.44
AXL P30530 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6647164 0.91 KDM4E (0.59) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6628863 0.88 CYP19A1 (0.48) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6628865 0.87 CYP19A1 (0.58) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6649987 0.87 KDM4E (0.56) KDM4ERAB9ACYP19A1SREBF2NPC1
SCHEMBL6652389 0.86 KDM4E (0.59) KDM4ERAB9ACYP19A1SREBF2NPC1
SCHEMBL6648675 0.86 EIF4E (0.58) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL6646768 0.85 CYP19A1 (0.56) RAB9ACYP19A1MAPTNPC1MEN1
SCHEMBL6649452 0.84 SMN1; SMN2 (0.51) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6626251 0.84 KDM4E (0.52) KDM4ERAB9ALMNASMN1; SMN2CYP19A1
SCHEMBL6648866 0.83 KDM4E (0.56) KDM4ERAB9ALMNASMN1; SMN2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed